Clincosm LogoSign in Get a demo

Non Hodgkin Lymphoma

Showing 76 - 100 of 127
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Non Hodgkin Lymphoma Trial in Guangzhou (ADG106 injection, PD-1 antibody injection)

Recruiting
  • Solid Tumor
  • Non Hodgkin Lymphoma
  • ADG106 injection
  • PD-1 antibody injection
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Jan 11, 2022

Non Hodgkin Lymphoma Trial in United States (AB-101, Rituximab, Interleukin-2)

Recruiting
  • Non Hodgkin Lymphoma
  • Birmingham, Alabama
  • +7 more
Dec 22, 2021

Hodgkin Lymphoma, Non Hodgkin Lymphoma, Myeloma Trial in Bergamo (Patient registry)

Recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Patient registry
  • Bergamo, Italy
    Hematology and Bone Marrow Transplant Unit, A.O. Ospedale Papa G
Dec 22, 2021

Hodgkin's Lymphoma, Lymphoid Leukemia, Lymphoma Trial in Richmond (mycophenolate mofetil, Sargramostim, Filgrastim)

Active, not recruiting
  • Hodgkin's Lymphoma
  • +17 more
  • mycophenolate mofetil
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Dec 21, 2021

Acute Myeloid Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (ZN-d5)

Recruiting
  • Acute Myeloid Leukemia
  • Non Hodgkin Lymphoma
  • Darlinghurst, New South Wales, Australia
  • +11 more
Dec 13, 2021

Hematologic Diseases, Acute Leukemia in Remission, Chronic Myelogenous Leukemia - Chronic Phase Trial in Ann Arbor (Vorinostat,

Recruiting
  • Hematologic Diseases
  • +11 more
  • Ann Arbor, Michigan
    University of Michigan Health System
Dec 2, 2021

Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Boston (Anakinra, Axicabtagene

Recruiting
  • Non Hodgkin Lymphoma
  • +5 more
  • Boston, Massachusetts
  • +1 more
Oct 28, 2021

Acute Myeloid Leukemia in Remission, MDS, Chronic Myeloid Leukemia in Remission Trial in Belgium (Thymoglobulin, Melphalan,

Recruiting
  • Acute Myeloid Leukemia in Remission
  • +9 more
  • Antwerp, Belgium
  • +9 more
Oct 5, 2021

GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

Recruiting
  • GVHD
  • +15 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 30, 2021

Relapsed T-Cell Lymphoma, Refractory T-Cell Lymphoma, Non Hodgkin Lymphoma Trial in Winston-Salem (CPI 613, Bendamustine)

Recruiting
  • Relapsed T-Cell Lymphoma
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Aug 27, 2021

Refractory and Relapsed Primary CNS Lymphoma, PCNSL, Non Hodgkin Lymphoma Trial in Guangzhou (Orelabrutinib, Thiotepa)

Not yet recruiting
  • Refractory and Relapsed Primary CNS Lymphoma
  • +2 more
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-sen University Cancer Ce
Aug 19, 2021

Non Hodgkin Lymphoma Trial in Australia, United States (Tenalisib,)

Completed
Has Results
  • Non Hodgkin Lymphoma
  • Huntsville, Alabama
  • +11 more
Jul 20, 2021

Cancer, Metastatic, Cancer, Cancer of Pancreas Trial in New York (Clinical Trial Matching)

Recruiting
  • Cancer, Metastatic
  • +42 more
  • Clinical Trial Matching
  • New York, New York
    Massive Bio, Inc
May 21, 2021

Acute Myeloid Leukemia, Hematologic Malignancies, Acute Lymphocytic Leukemia Trial in Cleveland (radiation, drug, procedure,

Completed
  • Acute Myeloid Leukemia
  • +10 more
  • total marrow irradiation
  • +7 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Seidman Cancer Ce
May 5, 2021

Acute Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma Trial in Marseille (Hematopoietic stem cells transplantation)

Active, not recruiting
  • Acute Leukemia
  • +2 more
  • Hematopoietic stem cells transplantation
  • Marseille, France
    Institut Paoli-Calmettes
Mar 26, 2021

Lung Cancer Metastatic, Locally Advanced Malignant Tumor, Non Hodgkin Lymphoma Trial in Marseille (Blood sample collection,

Active, not recruiting
  • Lung Cancer Metastatic
  • +3 more
  • Blood sample collection
  • Biopsy collection
  • Marseille, Bouches-du-Rhône, France
    Institut Paoli-Calmettes
Mar 26, 2021

Non Hodgkin Lymphoma Trial (biological, drug, radiation)

Withdrawn
  • Non Hodgkin Lymphoma
  • avelumab
  • +13 more
  • (no location specified)
Mar 17, 2021

Follicular Lymphoma, Non Hodgkin Lymphoma, Lymphoma Trial in Edmonds, Issaquah, Seattle (Tazemetostat, Rituximab)

Terminated
  • Follicular Lymphoma
  • +2 more
  • Edmonds, Washington
  • +2 more
Mar 1, 2021

Lung Cancer, Colorectal Cancer, Multiple Myeloma Trial in Avignon (other, biological, behavioral)

Recruiting
  • Lung Cancer
  • +3 more
  • Osteopathic intervention
  • +2 more
  • Avignon, France
    Centre Hospitalier Henri Duffaut
Jan 18, 2021

Non Hodgkin Lymphoma Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))

Terminated
Has Results
  • Non Hodgkin Lymphoma
  • Antineoplaston therapy (Atengenal + Astugenal)
  • Houston, Texas
    Burzynski Clinic
Jan 4, 2021

Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma

Completed
  • Non Hodgkin Lymphoma
  • bone marrow puncture and venous blood samples
  • venous blood samples
  • Assiut, Egypt
    AssiutU
Jan 12, 2021

Occupational Exposures in Acute Hematologic Malignancy

Completed
  • Non Hodgkin Lymphoma
  • +2 more
    • Bordeaux, France
    • +5 more
    Jul 31, 2020

    Patients With Non-Hodgkin's Lymphoma

    Recruiting
    • Non Hodgkin Lymphoma
      • Shanghai, China
        Shanghai Ruijin Hospital
      Jul 6, 2020

      Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma Trial in Denver, Nashville, Houston (TC-110 T

      Recruiting
      • Non Hodgkin Lymphoma
      • +5 more
      • TC-110 T Cells
      • +2 more
      • Denver, Colorado
      • +2 more
      Jun 25, 2020

      Hodgkin Disease, Non Hodgkin Lymphoma, Lymphoepithelioma Trial in Houston (LMP1/2 CTLs (ALCI - Group A), LMP1/2 CTLs (ALCI -

      Completed
      Has Results
      • Hodgkin Disease
      • +3 more
      • LMP1/2 CTLs (ALCI - Group A)
      • +8 more
      • Houston, Texas
      • +1 more
      May 26, 2020